PubMed:32301749 / 2110-2374
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T33 | 132-135 | GO:0071735 | denotes | IgM |
T34 | 140-143 | GO:0071735 | denotes | IgG |
T35 | 147-151 | UBERON:0001977 | denotes | sera |
T36 | 155-163 | SP_7 | denotes | COVID-19 |
T37 | 231-234 | GO:0071735 | denotes | IgM |
T38 | 239-242 | GO:0071735 | denotes | IgG |
T39 | 244-252 | SP_7 | denotes | COVID-19 |
T40 | 253-263 | GO:0042571 | denotes | antibodies |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T20 | 132-135 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T21 | 140-143 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T22 | 231-234 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T23 | 239-242 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T11 | 155-163 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 244-252 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
27 | 155-163 | Disease | denotes | COVID-19 | MESH:C000657245 |
28 | 164-172 | Species | denotes | patients | Tax:9606 |
29 | 244-252 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T15 | 0-264 | Sentence | denotes | Conclusions The findings of this study demonstrate the validity of the MAGLUMI 2000 Plus CLIA assay for the measurement of specific IgM and IgG in sera of COVID-19 patients, and for obtaining valuable data on the kinetics of both (IgM and IgG) COVID-19 antibodies. |